AƱoga, Neciel Faith T.
HRN: 21-94-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/16/2022
AMPICILLIN 250MG (VIAL)
09/16/2022
09/23/2022
IV
120mg
Q12
Pnsb
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes